30 related articles for article (PubMed ID: 25771081)
1. Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick SE; Lam TC
Plast Reconstr Surg; 2020 Aug; 146(2):117e-126e. PubMed ID: 32740565
[TBL] [Abstract][Full Text] [Related]
2. Incidence of occult carcinoma and high-risk lesions in mammaplasty specimens.
Freedman BC; Smith SM; Estabrook A; Balderacchi J; Tartter PI
Int J Breast Cancer; 2012; 2012():145630. PubMed ID: 23091731
[TBL] [Abstract][Full Text] [Related]
3. Projection of the number of new cases of breast cancer in the world.
Okawa S; Saika K
Jpn J Clin Oncol; 2023 Dec; 53(12):1215-1216. PubMed ID: 37997396
[No Abstract] [Full Text] [Related]
4. Diagnostic concordance among pathologists interpreting breast biopsy specimens.
Elmore JG; Longton GM; Carney PA; Geller BM; Onega T; Tosteson AN; Nelson HD; Pepe MS; Allison KH; Schnitt SJ; O'Malley FP; Weaver DL
JAMA; 2015 Mar; 313(11):1122-32. PubMed ID: 25781441
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of 8q23, 15q13 and 18q21 SNP genotyping to evaluate colorectal cancer risk.
Baert-Desurmont S; Charbonnier F; Houivet E; Ippolito L; Mauillon J; Bougeard M; Abadie C; Malka D; Duffour J; Desseigne F; Colas C; Pujol P; Lejeune S; Dugast C; Buecher B; Faivre L; Leroux D; Gesta P; Coupier I; Guimbaud R; Berthet P; Manouvrier S; Cauchin E; Prieur F; Laurent-Puig P; Lebrun M; Jonveaux P; Chiesa J; Caron O; Morin-Meschin ME; Polycarpe-Osaer F; Giraud S; Zaanan A; Bonnet D; Mansuy L; Bonadona V; El Chehadeh S; Duhoux F; Gauthier-Villars M; Saurin JC; Collonge-Rame MA; Brugières L; Wang Q; Bressac-de Paillerets B; Rey JM; Toulas C; Buisine MP; Bronner M; Sokolowska J; Hardouin A; Cailleux AF; Sebaoui H; Blot J; Tinat J; Benichou J; Frebourg T
Eur J Hum Genet; 2016 Jan; 24(1):99-105. PubMed ID: 25873010
[TBL] [Abstract][Full Text] [Related]
6. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
[TBL] [Abstract][Full Text] [Related]
7. Three-Pedicle Reduction Mammaplasty Technique in the Treatment of Greater Breast Hypertrophy Patients With or Without Breast Cancer: Surgical and Patient-reported outcomes.
Feng Y; Li J; Zhang D; Yang H; Qiu M; Zhou J; Qin X; Liu X; Liang F; Du Z
Aesthetic Plast Surg; 2023 Dec; 47(6):2221-2231. PubMed ID: 36820864
[TBL] [Abstract][Full Text] [Related]
8. Pathological Evaluation of Breast Specimens in Transgender Chest Masculinization: Incidental Findings and Effect of Prior Chest Binding and Androgen Therapy in 74 Consecutive Patients.
Schultz JJ; Naides AI; Bai D; Shulzhenko NO; Keith JD
Transgend Health; 2021 Dec; 6(6):353-357. PubMed ID: 34993306
[No Abstract] [Full Text] [Related]
9. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.
Hussain M; Cunnick GH
Eur J Surg Oncol; 2011 Apr; 37(4):279-89. PubMed ID: 21306860
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
[TBL] [Abstract][Full Text] [Related]
11. Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients.
Sorin T; Fyad JP; Delay E; Rouanet P; Rimareix F; Houpeau JL; Classe JM; Garrido I; Tunon De Lara C; Dauplat J; Bendavid C; Houvenaeghel G; Clough KB; Sarfati I; Leymarie N; Trudel M; Salleron J; Guillemin F; Oldrini G; Brix M; Dolivet G; Simon E; Verhaeghe JL; Marchal F
Breast; 2015 Jun; 24(3):272-7. PubMed ID: 25771081
[TBL] [Abstract][Full Text] [Related]
12. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
13. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
14. Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer.
Li Z; Fadare O; Hameed O; Zhao C; Desouki MM
Hum Pathol; 2014 Jan; 45(1):104-9. PubMed ID: 24182561
[TBL] [Abstract][Full Text] [Related]
15. Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma.
Wanis ML; Wong JA; Rodriguez S; Wong JM; Jabo B; Ashok A; Lum SS; Solomon NL; Reeves ME; Garberoglio CA; Senthil M
Am Surg; 2013 Oct; 79(10):1119-22. PubMed ID: 24160812
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
